X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF SURGICAL ONCOLOGY

期刊標題檢索 J SURG ONCOL 最新評論: A liver cancer meta, submitted on January 20th, had no updates for ov... (2024-05-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF SURGICAL ONCOLOGY]您好,您是該頁面的第 42424 位訪客。

期刊簡介
期刊名稱JOURNAL OF SURGICAL ONCOLOGY JOURNAL OF SURGICAL ONCOLOGY
LetPub Score
6.7
50 ratings
Rate

Reputation
7.5

Influence
5.3

Speed
9.6

期刊簡稱J SURG ONCOL
ISSN0022-4790
E-ISSN1096-9098
h-index101
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.700.8100.893
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Surgery
Q197 / 551
Category: Medicine
Subcategory: Oncology
Q2181 / 404

自引率 (2023-2024)5.00%自引率趨勢
掲載範囲
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9098
在線稿件提交http://mc.manuscriptcentral.com/jso
開放訪問No
出版商Wiley-Liss Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月2回刊行
創刊年0
每年文章數313每年文章數趨勢
黃金OA百分比13.31%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3221/322
SURGERYSCIEQ2108/290
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-4790%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【JOURNAL OF SURGICAL ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    ENDOSCOPYH-index: 129

    CiteScore: 5.80
    AMERICAN JOURNAL OF TRANSPLANTATIONH-index: 168

    CiteScore: 18.70
    British Journal of SurgeryH-index: 186

    CiteScore: 12.70
    ANNALS OF SURGERYH-index: 284

    CiteScore: 14.40
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERYH-index: 107

    CiteScore: 6.80
    Digestive EndoscopyH-index: 49

    CiteScore: 10.10
    LIVER TRANSPLANTATIONH-index: 137

    CiteScore: 7.40
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERYH-index: 144

    CiteScore: 9.30
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUMEH-index: 235

    CiteScore: 8.90
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCHH-index: 185

    CiteScore: 7.00
    學科內最受檢索的期刊 頁面查看次數
    Asian Journal of Surgery66206
    ANNALS OF SURGERY59940
    ANNALS OF SURGICAL ONCOLOGY58633
    JOURNAL OF SURGICAL RESEARCH53484
    SHOCK48854
    British Journal of Surgery45523
    EJSO44448
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES43326
    SURGERY41744
    WORLD JOURNAL OF SURGERY40251
  •  

    JOURNAL OF SURGICAL ONCOLOGY JOURNAL OF SURGICAL ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [JOURNAL OF SURGICAL ONCOLOGY] 的評論撰寫評論
作者: yh417


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-13 10:14:54 評論於
A liver cancer meta, submitted on January 20th, had no updates for over a month. An email was sent to urge the process at the end of February, and it was then put under review. On March 8th, a major revision was requested with a three-month deadline, and a response was given within two weeks. Minor revisions were made on April 7th. The submission website was changed to Wiley halfway through the process, and the article was resubmitted on April 20th. Finally, it was accepted on May 11th
(0) 讚! | yh417

作者: 是你的笑丝呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-16 20:34:47 評論於
How did he figure out the citation errors in the reference list?
(0) 讚! | 是你的笑丝呀

作者: 格洛丽亚瑞林


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-10 09:29:39 評論於
Review Speed: 1.0 | Acceptance Rate: 25.0 Emphasis on research direction: Liver cancer Experience sharing: Submitted on 2023.1.6, rejected on 1.9, the review was fast enough, but no reason given
(0) 讚! | 格洛丽亚瑞林

作者: 博泽少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-29 12:38:51 評論於
Main research focus: Tumors; Cancer; Prognosis
Experience sharing: Submitted on 11.30, under review. Received comments from one associate editor and one reviewer on 12.29, with a 3-month revision period. Completed revisions and now waiting for the final decision. Overall, the process has been very fast
(0) 讚! | 博泽少爷

作者: 北风梓璐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-30 13:25:04 評論於
Is there an option in this magazine where we don't have to pay for the editorial fee?
(0) 讚! | 北风梓璐

作者: Abner Maria


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-30 09:39:38 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Research focus: Cancer; Clinical Experience: #Clinical Retrospective Analysis# 
[HU] Sharing submission experience is like giving roses ?
10-1 submitted 
10-1 under review
10-27 awaiting EIC Decision
10-29 Reject
Rejection letter details:
Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions.
Summary: The review process is fast, focusing on large sample clinical studies, with retrospective analysis of cases fewer than 100 generally not accepted
(0) 讚! | Abner Maria

作者: guanhong123


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-28 23:46:46 評論於
May I ask if your article is of the research type or review type? I heard that meta takes a bit longer, is that true? I submitted a meta article and it is still under review.
(0) 讚! | guanhong123

作者: guanhong123


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-28 23:43:49 評論於
Did the paper get rejected after being revised?
(0) 讚! | guanhong123

作者: 太虚安澜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-28 16:41:12 評論於
As soon as I submitted it, it is under review. May I ask how long it takes to receive the review comments?
(0) 讚! | 太虚安澜

作者: Miranda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-18 09:39:11 評論於
Instant rejection, rejected to the point of doubting life
(0) 讚! | Miranda

作者: Miranda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-17 23:36:14 評論於
Hey guys, how long until the situation changes?
(0) 讚! | Miranda

作者: Miranda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-16 10:26:44 評論於
Emphasis on research direction: Hepatocellular carcinoma radiotherapy; prognosis; clinical experience sharing: Does anyone have any big names to share submissions to this journal?
(0) 讚! | Miranda

作者: 一只幻南呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-01 20:52:56 評論於
It seems that this magazine is just like this
(0) 讚! | 一只幻南呀

作者: 金顶代丹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-30 13:48:22 評論於
Is anyone else having trouble uploading pictures? How do I go about fixing this craziness?
(0) 讚! | 金顶代丹

作者: Catcher


領域: 医学
審稿時間: 9.0 month(s)
結果: 直接被接受


撰寫評論

2022-05-01 10:15:34 評論於
The submission period mentioned above is incorrect. Professors, please disregard that. The review process is fast, so you can give it a try!
(0) 讚! | Catcher

作者: Catcher


領域: 医学
審稿時間: 9.0 month(s)
結果: 直接被接受


撰寫評論

2022-05-01 10:13:40 評論於
3.30 submitted, accepted in the early morning of 5.1, submitted for a month, no revisions required, accepted directly, very fast process, thumbs up (previously had to revise twice for another lower-ranked journal, reviewers were all satisfied, but the editor rejected it, took six months, felt disgusted).
(3) 讚! | Catcher

作者: 冰心凝蝶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-29 20:07:52 評論於
Hello, I have been waiting for a week after submitting my manuscript. It has been "Under Review" all this time. How do I know if it has been sent for external review?
(0) 讚! | 冰心凝蝶

作者: 冰心凝蝶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-29 19:21:35 評論於
How do I know if it has been sent for external review? I have been under review for a week since submitting my contribution
(0) 讚! | 冰心凝蝶

作者: 冰心凝蝶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-29 16:24:08 評論於
Hello, it has been 1 week since I submitted my manuscript, and it is still Under Review. Is the journal considering sending it out for external review?
(0) 讚! | 冰心凝蝶

作者: 冰心凝蝶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-29 08:40:10 評論於
Hello, how do you see if it has been sent for external review? It is still Under Review from the beginning
(0) 讚! | 冰心凝蝶

作者: Perry Adam


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-28 15:14:05 評論於
Within a month, three months were given to modify, and then rejected
(0) 讚! | Perry Adam

作者: Perry Adam


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-28 08:12:46 評論於
Within one month
(0) 讚! | Perry Adam

作者: 极乐景逸


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-09 20:10:53 評論於
Does this magazine accept articles related to genetics?
(0) 讚! | 极乐景逸

作者: Martina Jeremy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-23 23:35:31 評論於
Submission hit rate: 25.0
Research orientation: Tumor
Experience sharing: The submission was rejected after 1 day, with a claim of a 15% acceptance rate
(0) 讚! | Martina Jeremy

作者: Norma Jane


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-02 12:06:56 評論於
Rejected the next day
(0) 讚! | Norma Jane

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [JOURNAL OF SURGICAL ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*